TGTX TG Therapeutics Inc

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

$13.79  -0.36 (-2.54%)
As of 01/27/2023 11:12:31 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  145,341,967
Average volume:  6,296,429
Market cap:   $2,056,588,833
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B828K63
Valuation   (See tab for details)
PE ratio:   -6.43
PB ratio:   11.12
PS ratio:   259.93
Return on equity:   -191.62%
Net income %:   -4,126.47%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy